Friday, 29 May 2026
  
Login

Australia's most trusted
source of pharma news

Friday, 29 May 2026
News

$17.7B bid to take pharma private

Posted 28 May 2026 PM

Private equity firm CVC Capital Partners and Belgian investment group Groupe Bruxelles Lambert have teamed up to launch an offer to take Recordati private with a bid that values the Italian drugmaker at 10.73 billion euros (AUD$17.7 billion).

The tender offer values Recordati at 51.29 euros a share, almost 13 per cent above its price before a CVC takeover approach, with the aim of delisting Recordati from the Euronext Milan in March

To see the whole article, please login

Popular

Exec exits with pointed sign-off
Drug pulled after viability review
Oncology dethroned as No 1
Senior exec leaves pharma
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (1)

Sales & Customer Relations (18)

Clinical & Medical, R&D (5)

Regulatory, Pharmacovigilance & QA (3)

Other (8)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2026 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home